Indian drugmaker, Cipla Ltd, sees GLP-1 drugs, used to treat type-2 diabetes and obesity, as a significant new therapy opportunity in the Indian market.

I just thought the hustle and bustle of keeping up with everything was exhausting me. I continuously complained to my therapist that I ...

Previous studies have suggested the drugs may slash the risk of illnesses like dementia and stroke, with an international ...

Cipla reports a 10% YoY rise in Q1FY26 net profit, driven by strong performance in consumer healthcare and generics. The ...

WOMEN and older adults who use increasingly popular weight-loss drug semaglutide could protect themselves from a common side ...

Empower Pharmacy, a Houston-based compounding pharmacy, has been sanctioned by the FDA and other states in the past decade.

Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...

Researchers says the drugs could be a treatment for obese people with asthma who are ‘often resistant’ to steroids ...

From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...

GLP-1 agonists and dual agonists can cause hypoglycemia, nausea, and more. But there are ways to lessen the side effects, so you can keep taking the medication.

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...